Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 17.20 INR
Change Today +0.65 / 3.93%
Volume 1.3K
ALPA On Other Exchanges
Symbol
Exchange
Natl India
As of 4:00 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

alpa laboratories ltd (ALPA) Snapshot

Open
16.05
Previous Close
16.55
Day High
17.20
Day Low
16.05
52 Week High
10/31/14 - 21.70
52 Week Low
09/4/14 - 9.15
Market Cap
361.9M
Average Volume 10 Days
27.9K
EPS TTM
-2.45
Shares Outstanding
21.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALPA LABORATORIES LTD (ALPA)

Related News

No related news articles were found.

alpa laboratories ltd (ALPA) Related Businessweek News

No Related Businessweek News Found

alpa laboratories ltd (ALPA) Details

Alpa Laboratories Limited manufactures and markets pharmaceutical finished dosage forms to various pharmaceutical companies primarily in India. The company offers its products formulations in various finished dosage forms, including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. It provides products in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoans, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular products; anti-diabetics; nutritional supplements; psychotropic drugs; skin care preparations; and ear and eye care preparations. Alpa Laboratories Limited sells its products through distributors, as well as retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to various countries in South and Central America, Africa, and Asia, including CIS countries comprising Russia, Ukraine, Kazakhstan, etc. Alpa Laboratories Limited was incorporated in 1988 and is based in Indore, India.

Founded in 1988

alpa laboratories ltd (ALPA) Top Compensated Officers

Executive Chairman, Managing Director, Member...
Total Annual Compensation: 2.7M
Whole Time Director and Member of Shareholder...
Total Annual Compensation: 2.7M
Whole Time Director
Total Annual Compensation: 2.5M
Compensation as of Fiscal Year 2014.

alpa laboratories ltd (ALPA) Key Developments

Alpa Laboratories Ltd. Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Audited Standalone and Consolidated Earnings Results for the Year Ended March 31, 2015

Alpa Laboratories Ltd. reported unaudited standalone earnings results for the fourth quarter and audited standalone and consolidated earnings results for the year ended March 31, 2015. For the quarter, on standalone basis the company reported net sales/income from operations of INR 147.577 million compared to INR 178.819 million a year ago. Loss from operations before other income and finance costs was INR 17.688 million compared to INR 0.577 million a year ago. Loss from ordinary activities before tax was INR 7.728 million compared to INR 10.915 million a year ago. Net profit after tax and extraordinary items was INR 5.665 million or INR 0.27 per basic and diluted share after extraordinary items against net loss after tax and extraordinary items of INR 11.471 million or INR 0.55 per basic and diluted share after extraordinary items a year ago. For the year, on standalone basis the company reported net sales/income from operations of INR 567.061 million compared to INR 546.989 million a year ago. Loss from operations before other income and finance costs was INR 26.483 million compared to INR 33.967 million a year ago. Loss from ordinary activities before tax was INR 15.624 million compared to INR 49.512 million a year ago. Net loss after tax and extraordinary items was INR 13.968 million or INR 0.66 per basic and diluted share after extraordinary items against INR 51.548 million or INR 2.45 per basic and diluted share after extraordinary items a year ago. For the year, on consolidated basis the company reported net sales/income from operations of INR 567.061 million compared to INR 546.989 million a year ago. Loss from operations before other income and finance costs was INR 26.492 million compared to INR 33.967 million a year ago. Loss from ordinary activities before tax was INR 15.633 million compared to INR 49.512 million a year ago. Net loss after tax and extraordinary items was INR 13.977 million or INR 0.66 per basic and diluted share after extraordinary items against INR 51.548 million or INR 2.45 per basic and diluted share after extraordinary items a year ago.

Alpa Laboratories Ltd to Report Q4, 2015 Results on May 29, 2015

Alpa Laboratories Ltd announced that they will report Q4, 2015 results on May 29, 2015

Alpa Laboratories Ltd, Board Meeting, May 29, 2015

Alpa Laboratories Ltd, Board Meeting, May 29, 2015. Agenda: To consider and approve the financial results for the quarter and period ended March 31, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALPA:IN 17.20 INR +0.65

ALPA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALPA.
View Industry Companies
 

Industry Analysis

ALPA

Industry Average

Valuation ALPA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 0.4x
Price/Cash Flow 7.3x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALPA LABORATORIES LTD, please visit www.alpalabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.